New molecular aspects for the diagnosis and treatment of neuroendocrine gastroenteropancreatic tumors.
Wiedenmann
B
B
Department of Internal Medicine, Klinikum Steglitz der Freien Universität Berlin, Germany.
Ahnert-Hilger
G
G
Kvols
L K
LK
Riecken
E O
EO
D000818:Animals; D001692:Biological Transport; D019204:GTP-Binding Proteins / Q000502:physiology; D006728:Hormones / Q000096:biosynthesis; D006801:Humans; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D018377:Neurotransmitter Agents / Q000096:biosynthesis; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D011956:Receptors, Cell Surface / Q000502:physiology; D015398:Signal Transduction; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*
D006728:Hormones; D018377:Neurotransmitter Agents; D011956:Receptors, Cell Surface; D019204:GTP-Binding Proteins